viewCB2 Insights Inc.

Buds & Duds: Cannabis stocks slide on Thursday; CB2 Insights shares pop on acquisition

Also on the move were International Cannabis Corp, Planet 13 Holdings Inc and Isodiol International Inc

CB2 announced it has acquired the assets of Colorado-based medical cannabis clinic group Relaxed Clarity

Cannabis stocks tripped on Thursday after significant gains on Wednesday. While the majority of cannabis players have had a bumping 2019 when it comes to stock prices, concerns remain about what lies ahead. 

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, dropped 1% to 305.61. The Horizons Marijuana Life Sciences Index ETF was down 0.7% at C$21.57. 


CB2 Insights (CSE:CBII) shares soared on Thursday after the medical cannabis-focused data firm announced it has acquired the assets of Colorado-based medical cannabis clinic group Rae of Sunshine Health Services LLC, operating as Relaxed Clarity. 

Shares of the Toronto-based company were up 8.5% at C$0.32. 

WATCH: CB2 Insights adds another asset with acquisition of Colorado based Relaxed Clarity

International Cannabis Corp (CSE:WRLD.U) (OTCMKTS:WLDCF) shares were bolstered Thursday by the news that it may soon be listed on a major international exchange. 

The cannabis company is pursuing a public listing on either the Nasdaq, the New York Stock Exchange or the AIM in London.

Shares were up 4.2% at US$0.32 in New York. 

READ: International Cannabis ponders listing on major international exchange

Other gainers Thursday included Planet 13 Holdings Inc (CSE:PLTH), which continued its rise from earlier in the week. 

On Wednesday, the company reported US$5.49 million in revenue from its Las Vegas Cannabis Entertainment Complex in March 2019, which is the world's largest cannabis dispensary. The company said in March, almost 100,000 people entered the dispensary.

Shares were up 9.5% at C$3.01 in Toronto. 


Isodiol International Inc (OTCQB:ISOLF) (CSE:ISOL) shares dropped Thursday, down 3.2% to US$1.05. The Vancouver-based company develops hemp-based consumer markets for distribution in Canada, Latin America, Asia, and Europe.

Other laggards on Thursday included Flower One Holdings (CSE:FONE), which was down 5.2% at C$2.75 in Toronto and Newstrike Brands (CVE:HIP), which was down 3.7% at C$0.52. 


Contact Katie Lewis at [email protected]

Quick facts: CB2 Insights Inc.

Price: 0.1 CAD

Market: CSE
Market Cap: $8.28 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of CB2 Insights Inc. named herein, including the promotion by the Company of CB2 Insights Inc. in any Content on the Site, the Company receives...



Full interview: CB2 Insights announces key partnership with GL Brands for...

CB2 Insights ((CSE: CBII; OTCQB: CBIIF) CEO Prad Sekar joined Steve Darling from our Toronto studio to provide details the will begin a prospective trial with GL Brands that will assess the safety, efficacy and other health measures for patients using Green Lotus’ cannabidiol soft gel capsules...

on 12/17/2019

2 min read